Glenmark initiates multi-country Phase 3 clinical trial for Envafolimab in resectable Stage III NSCLC
The company has received approval from DCGI to begin patient enrolment and dosing in the country
The company has received approval from DCGI to begin patient enrolment and dosing in the country
Under the partnership, the Pfizer INDovation program will empower DPIIT-recognized startups with grants of up to Rs. 60 lakhs each, along with a tailored 18-month incubation program delivered by Social Alpha
The hospital opens with 300 operational beds, including 100+ ICU beds and 5 advanced operating theatres
Treatment with Verzenio also resulted in sustained invasive disease-free survival and distant relapse-free survival benefit
The new lineup includes CereTom Elite, OmniTom Elite, OmniTom Elite PCD, and BodyTom 32/64
Investment supports Company’s plans to manufacture the vast majority of advanced medicines in the U.S. to meet the needs of patients in the U.S.
Fourteenth breakthrough therapy designation granted by FDA across the oncology portfolio of Daiichi Sankyo
The projected business potential is around US$ 1 million in the first year
The new facility will enhance AbbVie’s chemical synthesis capacity to support domestic production of current and next-generation neuroscience, immunology, and oncology medicines
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
Subscribe To Our Newsletter & Stay Updated